Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2142-2146 , November 2005

Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device

,Accepted 27 April 2005.

References 

  1. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study; the Endophthalmitis Vitrectomy Study Group. Am J Ophthalmol. 1996;122:1–17correction, 920
  2. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother. 1997;40:639–651
  3. Osato MS, Jenson HG, Trousdale MD, et al. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380–386correction, 1991; 112:478–479
  4. Mather R, Karanchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463–466
  5. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500–505
  6. Taravella MJ, Balentine J, Young DA, Stepp P. Collagen shield delivery of ofloxacin to the human eye. J Cataract Refract Surg. 1999;25:562–565
  7. Willoughby CE, Batterbury M, Kaye SB. Collagen corneal shields. Surv Ophthalmol. 2002;47:174–182
  8. Şimşek NA, Ay GM, Tugal-Tutkun I, et al. An experimental study on the effect of collagen shields and therapeutic contact lenses on corneal wound healing. Cornea. 1996;15:612–616
  9. Unterman SR, Rootman DS, Hill JM, et al. Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor. J Cataract Refract Surg. 1988;14:500–504
  10. Phinney RB, Schwartz SD, Lee DA, Mondino BJ. Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol. 1988;106:1599–1604
  11. Chen C-C, Takruri H, Duzman E. Enhancement of the ocular bioavailability of topical tobramycin with use of a collagen shield. J Cataract Refract Surg. 1993;19:242–245
  12. O'Brien TP, Sawusch MR, Dick JD, et al. Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycin. J Cataract Refract Surg. 1988;14:505–507
  13. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24
  14. Hariprasad SM, Blinder KJ, Shah GK, et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol. 2005;123:39–44
  15. Stass H, Dalhoff A. Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. J Chromatogr B Biomed Sci Appl. 1997;702:163–174
  16. Clark WL, Kaiser PK, Flynn HW, et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106:1665–1670
  17. Kuwano M, Horibe Y, Kawashima Y. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J Ocul Pharmacol Ther. 1997;13:31–40
  18. Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol. 2003;136:300–305

 Presented in part at the 140th Annual Meeting of the American Ophthalmological Society, Hot Springs, Virginia, May 2004.Supported by the Retina Research and Development Foundation, St. Louis, Missouri, USA.No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(05)00675-9

doi: 10.1016/j.jcrs.2005.04.028

Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2142-2146 , November 2005